Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  KOREA EXCHANGE  >  Samsung Biologics Co Ltd    207940   KR7207940008

SAMSUNG BIOLOGICS CO LTD

(207940)
  Report  
SummaryNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Samsung Biologics : S. Korean stocks close highest in about 3 weeks

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/12/2019 | 03:42am EDT

South Korean stocks gained ground on Friday.

The benchmark Korea Composite Stock Price Index (KOSPI) gained 12.29 points, or 0.60 percent, to settle at 2,075.57. Trading volume stood at 372.5 million shares worth 4.5 trillion won (4 billion U.S. dollars).

It was the highest close in about three weeks.

Many of blue-chip stocks ended in positive territory. Market bellwether Samsung Electronics rose 1.8 percent, and leading chemical firm LG Chem added 0.6 percent. Samsung BioLogics, a biopharmaceutical unit of Samsung Group, the country`s biggest family-controlled conglomerate, climbed 1.9 percent.

The state-run power supplier Korea Electric Power Corp. gained 0.7 percent, but memory chip giant SK Hynix dipped 0.3 percent. The biggest mobile operator SK Telecom declined 2.8 percent, and the biggest steelmaker POSCO lost 1.2 percent.

South Korea`s currency finished at 1,116.4 won against the greenback, up 1.9 won from the previous close.

Bond prices ended lower. Yields on the liquid three-year treasury notes added 0.8 basis points to 1.804 percent, and the return on the 10-year government bonds went up 2.8 basis points to 1.992 percent.

(c) 2019 ITP Business Publishing Ltd. All Rights Reserved. Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

Stocks mentioned in the article
ChangeLast1st jan.
KOREA ELECTRIC POWER CORPORATION End-of-day quote.
SAMSUNG BIOLOGICS CO LTD End-of-day quote.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SAMSUNG BIOLOGICS CO LTD
06/17Samsung scrambles to deal with growing uncertainties
AQ
06/14SAMSUNG ELECTRONICS : president grilled amid biotech accounting scandal
AQ
06/12SAMSUNG ELECTRONICS : president grilled about accounting scandal at biotech affi..
AQ
06/12SAMSUNG ELECTRONICS : president grilled about accounting scandal at biotech affi..
AQ
06/12SAMSUNG ELECTRONICS : Prosecution summons Samsung exec over alleged role in biot..
AQ
06/12SAMSUNG ELECTRONICS : Prosecution summons Samsung exec over alleged role in biot..
AQ
05/27SAMSUNG BIOLOGICS : S Korea arrest warrants approved in Samsung accounting scand..
AQ
05/27SAMSUNG BIOLOGICS : Court rejects arrest warrant for Samsung BioLogics CEO
AQ
05/24SAMSUNG ELECTRONICS : South Korea orders further arrests at Samsung Electronics ..
RE
05/22Samsung Underlines Commitment to Nurturing Young Talent with Sponsorship of W..
AQ
More news
Financials (KRW)
Sales 2019 583 B
EBIT 2019 39,7 B
Net income 2019 24,4 B
Finance 2019 356 B
Yield 2019 -
P/E ratio 2019 785,75
P/E ratio 2020 95,05
EV / Sales 2019 34,1x
EV / Sales 2020 22,0x
Capitalization 20 213 B
Chart SAMSUNG BIOLOGICS CO LTD
Duration : Period :
Samsung Biologics Co Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 438 889  KRW
Spread / Average Target 44%
EPS Revisions
Managers
NameTitle
Tae-Han Kim Chief Executive Officer & Director
Ho-Yeol Yoon Managing Director & Head-Operations Support
Dong-Joong Kim Director & Head-Management Support
Seok-Woo Jung Outside Director
Byeong-Cheol Yoon Outside Director
Sector and Competitors
1st jan.Capitalization (M$)
SAMSUNG BIOLOGICS CO LTD16 821
CSL LIMITED16.22%64 329
BIOGEN-22.98%43 310
ALEXION PHARMACEUTICALS23.40%25 574
GRIFOLS8.52%16 048
BIOMARIN PHARMACEUTICAL INC.-1.15%14 696